A step forward for LRRK2 inhibitors in Parkinson’s disease
Patrick A. Lewis
Abstract
A phase 1 clinical trial for kinase inhibitors targeting LRRK2 provides the foundation for testing the efficacy of LRRK2 kinase inhibitors in Parkinson's disease.
Topics & Concepts
LRRK2Parkinson's diseaseMedicineDiseaseInternal medicineParkinson's Disease Mechanisms and TreatmentsPlant Gene Expression AnalysisGinkgo biloba and Cashew Applications